SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

79 hedge funds and large institutions have $464M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
+15
Holders Change %
+23.44%
% of All Funds
1.62%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
20
Increased
36
Reduced
16
Closed
5
Calls
$941K
Puts
Net Calls
+$941K
Net Calls Change
+$330K
Name Holding Trade Value Shares
Change
Shares
Change %
Osaic Holdings
76
Osaic Holdings
Arizona
$7K
PAG
77
Private Advisor Group
New Jersey
$3K +$3K +30 New
Daiwa Securities Group
78
Daiwa Securities Group
Japan
$2K
Group One Trading
79
Group One Trading
Illinois
$2K +$2K +20 New
DM
80
Deerfield Management
New York
-$7.53M -126,895 Closed
Invesco
81
Invesco
Georgia
-$534K -9,001 Closed
AP
82
AlpInvest Partners
Netherlands
-$89K -1,500 Closed
Squarepoint
83
Squarepoint
New York
-$68K -1,151 Closed
Victory Capital Management
84
Victory Capital Management
Texas
-$46K -779 Closed